HomeAPVO • NASDAQ
add
Aptevo Therapeutics Inc
Previous close
$3.82
Day range
$3.08 - $3.84
Year range
$3.01 - $399.60
Market cap
1.55M USD
Avg Volume
46.32K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.42M | 2.55% |
Net income | -6.31M | -6.93% |
Net profit margin | — | — |
Earnings per share | -8.94 | 96.26% |
EBITDA | -6.31M | -0.69% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.71M | -48.45% |
Total assets | 15.59M | -37.24% |
Total liabilities | 10.84M | -14.14% |
Total equity | 4.76M | — |
Shares outstanding | 1.46M | — |
Price to book | 1.17 | — |
Return on assets | -103.82% | — |
Return on capital | -158.73% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -6.31M | -6.93% |
Cash from operations | -5.76M | -9.63% |
Cash from investing | — | — |
Cash from financing | 6.72M | 120.62% |
Net change in cash | 961.00K | 143.54% |
Free cash flow | -3.42M | -4.45% |
About
Founded
2016
Headquarters
Website
Employees
37
